Seeing Is Believing
Currently out of the existing stock ratings of Greg Harrison, 68 are a BUY (68%), 25 are a HOLD (25%), 7 are a SELL (7%).
Analyst Greg Harrison, currently employed at SCOTIABANK, carries an average stock price target met ratio of 54.51% that have a potential upside of 38.4% achieved within 128 days.
Greg Harrison’s has documented 196 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KROS, Keros Therapeutics at 12-May-2025.
Analyst best performing recommendations are on OMER (OMEROS).
The best stock recommendation documented was for OMER (OMEROS) at 11/8/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.2 (6.25%) receiving and performance score of 62.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$6.25
$6.24 (62400.00%)
$25
3 years ago
(23-May-2022)
1/3 (33.33%)
$0.9 (16.82%)
14
Buy
$11
4 years 3 months 6 days ago
(17-Feb-2021)
1/1 (100%)
$-23.25 (-67.88%)
998
Buy
$125
$124.57 (28969.77%)
5 years 15 days ago
(08-May-2020)
0/1 (0%)
$54 (76.06%)
Which stock is Greg Harrison is most bullish on?
Which stock is Greg Harrison is most reserved on?
What Year was the first public recommendation made by Greg Harrison?